New data indicates that retatrutide, a dual-action medication, may represent a considerable improvement in weight loss . This drug combines the effects of a GLP-1 receptor and a GIP receptor , possibly offering a more benefit than available solutions. Patient assessments have revealed positive outcomes, including significant declines in size and a